S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
Massive Supercycle Investment Opportunities for 2022-2027 (Ad)pixel
'The Sacrifice Zone': Myanmar bears cost of green energy
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Closing prices for crude oil, gold and other commodities
Massive Supercycle Investment Opportunities for 2022-2027 (Ad)pixel
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
Wall Street slips as weak earnings hit tech, travel stocks
Massive Supercycle Investment Opportunities for 2022-2027 (Ad)pixel
S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
Massive Supercycle Investment Opportunities for 2022-2027 (Ad)pixel
'The Sacrifice Zone': Myanmar bears cost of green energy
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Closing prices for crude oil, gold and other commodities
Massive Supercycle Investment Opportunities for 2022-2027 (Ad)pixel
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
Wall Street slips as weak earnings hit tech, travel stocks
Massive Supercycle Investment Opportunities for 2022-2027 (Ad)pixel
S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
Massive Supercycle Investment Opportunities for 2022-2027 (Ad)pixel
'The Sacrifice Zone': Myanmar bears cost of green energy
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Closing prices for crude oil, gold and other commodities
Massive Supercycle Investment Opportunities for 2022-2027 (Ad)pixel
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
Wall Street slips as weak earnings hit tech, travel stocks
Massive Supercycle Investment Opportunities for 2022-2027 (Ad)pixel
S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
Massive Supercycle Investment Opportunities for 2022-2027 (Ad)pixel
'The Sacrifice Zone': Myanmar bears cost of green energy
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Closing prices for crude oil, gold and other commodities
Massive Supercycle Investment Opportunities for 2022-2027 (Ad)pixel
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
Wall Street slips as weak earnings hit tech, travel stocks
Massive Supercycle Investment Opportunities for 2022-2027 (Ad)pixel
NASDAQ:ANGN

Angion Biomedica - ANGN Earnings Date, Estimates & Call Transcripts

$1.03
-0.02 (-1.90%)
(As of 08/9/2022 12:00 AM ET)
Add
Compare
Today's Range
$1.01
$1.08
50-Day Range
$0.99
$2.02
52-Week Range
$0.98
$14.18
Volume
95,034 shs
Average Volume
123,610 shs
Market Capitalization
$30.86 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$41.00

Earnings Summary

Upcoming
Earnings Date
Aug. 11Estimated
Actual EPS
(May. 16)
-$0.48 Missed By -$0.04
Consensus EPS
(May. 16)
-$0.44
Last Year's Q2 EPS
(5/16/2021)
-$1.56
Skip Charts & View Estimated and Actual Earnings Data

ANGN Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ANGN Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Angion Biomedica Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20221($0.42)($0.42)($0.42)
Q4 20221($0.31)($0.31)($0.31)

ANGN Earnings Date and Information

Angion Biomedica last issued its quarterly earnings data on May 16th, 2022. The reported ($0.48) earnings per share for the quarter, missing the consensus estimate of ($0.44) by $0.04. The firm earned $1.65 million during the quarter, compared to analyst estimates of $1.23 million. Angion Biomedica has generated ($1.01) earnings per share over the last year (($1.01) diluted earnings per share). Earnings for Angion Biomedica are expected to grow in the coming year, from ($1.87) to ($1.82) per share. Angion Biomedica has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 11th, 2022 based off prior year's report dates.

Angion Biomedica Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/11/2022
(Estimated)
        
5/16/2022Q1 2022($0.44)($0.48)($0.04)($0.48)$1.23 million$1.65 million
3/30/2022Q4 2021($0.59)$0.58+$1.17$0.58$1.98 million$25.94 million
11/12/20219/30/2021($0.73)($0.53)+$0.20($0.53)$1.08 million$1.46 million
8/11/20216/30/2021($0.69)($0.58)+$0.11($0.58)$1.08 million$0.54 million    
5/16/2021Q1($0.6230)($1.56)($0.9370)($0.32)$3.28 million$0.37 million
3/29/2021Q4 2020($1.30)($1.90)($0.60)($1.90)$3.30 million$0.46 million












Angion Biomedica Earnings - Frequently Asked Questions

When is Angion Biomedica's earnings date?

Angion Biomedica has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 11th, 2022 based off last year's report dates. Learn more on ANGN's earnings history.

Did Angion Biomedica beat their earnings estimates last quarter?

In the previous quarter, Angion Biomedica (NASDAQ:ANGN) missed the analysts' consensus estimate of ($0.44) by $0.04 with a reported earnings per share (EPS) of ($0.48). Learn more on analysts' earnings estimate vs. ANGN's actual earnings.

How much revenue does Angion Biomedica generate each year?

Angion Biomedica (NASDAQ:ANGN) has a recorded annual revenue of $28.31 million.

How much profit does Angion Biomedica generate each year?

Angion Biomedica (NASDAQ:ANGN) has a recorded net income of -$54.57 million. ANGN has generated -$1.01 earnings per share over the last four quarters.

What is Angion Biomedica's EPS forecast for next year?

Angion Biomedica's earnings are expected to grow from ($1.87) per share to ($1.82) per share in the next year.

More Earnings Resources from MarketBeat

Upcoming Earnings:
This page (NASDAQ:ANGN) was last updated on 8/10/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.